Ticker: DYN

Company: Dyne Therapeutics, Inc.

Person: Johanna Friedl-Naderer, officer

Transaction date: Dec. 5, 2025

Reporting date: Dec. 5, 2025

Average share price: 20.72

Sold 144.0 shares for 2983.68